TOMM40L: A Potential Drug Target and Biomarker for Mitochondrial Dysfunction

Target Name: TOMM40L

NCBI ID: G84134

TOMM40L

TOMM40L: A Potential Drug Target and Biomarker for Mitochondrial Dysfunction

Mitochondria are essential organelles responsible for generating energy in the form of ATP during cellular processes. Their dysfunction has been implicated in a wide range of diseases, including neurodegenerative disorders, cardiovascular diseases, and metabolic disorders. The protein TOMM40L, also known as translocase of outer mitochondrial membrane 40 homolog-like, has been identified as a potential drug target and biomarker for mitochondrial dysfunction.

TOMM40L: Structure and Function

TOMM40L is a protein that belongs to the mitochondrial outer membrane protein (MOM) family. It is located on the outer mitochondrial membrane and is involved in the transfer of electrons during processes such as proton motive force (PMF) utilization and ATP production. TOMM40L functions as a translocase, which means it transfers electrons from the inner mitochondrial membrane to the outer membrane.

TOMM40L is a 21-kDa protein that consists of 129 amino acids. It has a characteristic Rossmann-fold structure, which is a type of hydrogen bonding-containing secondary structure that is common in proteins that involve electron transfer. The Rossmann-fold is responsible for the stability of the protein and is a key factor in its function as a translocase.

TOMM40L has been shown to play a crucial role in regulating PMF utilization, which is the energy-producing process that occurs in the mitochondria. PMF utilization is critical for maintaining cellular energy homeostasis and is a key factor in the development and progression of many diseases, including neurodegenerative disorders.

TOMM40L has also been shown to play a role in the regulation of ATP production. ATP is a crucial energy source for cellular processes and is involved in a wide range of cellular functions, including muscle contractions, vasodilation, and neurotransmitter release. TOMM40L has been shown to regulate the rate of ATP production by ensuring that electrons are transferred to the outer membrane to support the transfer of protons across the inner and outer membranes.

Drug Targeting

TOMM40L has been identified as a potential drug target for several reasons. Firstly, TOMM40L is a protein that is expressed in high levels in certain diseases, such as Alzheimer's disease and Parkinson's disease. Secondly, TOMM40L is involved in the regulation of several cellular processes that are implicated in the development and progression of these diseases. Finally, TOMM40L has been shown to play a role in the transfer of electrons during PMF utilization, which is a key process in the development of neurodegenerative disorders.

Biomarker

TOMM40L has also been identified as a potential biomarker for mitochondrial dysfunction. Mitochondrial dysfunction is a condition in which the mitochondria are unable to generate enough ATP or are damaged and cannot function properly. This condition has been implicated in a wide range of diseases, including neurodegenerative disorders, cardiovascular diseases, and metabolic disorders.

TOMM40L has been shown to be involved in the regulation of PMF utilization, which is a key process in the development and progression of mitochondrial dysfunction. By ensuring that electrons are transferred to the outer membrane to support the transfer of protons across the inner and outer membranes, TOMM40L plays a crucial role in maintaining the proper functioning of the mitochondria. Therefore, TOMM40L may be a useful biomarker for the diagnosis and treatment of mitochondrial dysfunction.

Conclusion

TOMM40L is a protein that is located on the outer

Protein Name: Translocase Of Outer Mitochondrial Membrane 40 Like

Functions: Potential channel-forming protein implicated in import of protein precursors into mitochondria

The "TOMM40L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TOMM40L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets